188 related articles for article (PubMed ID: 37947594)
21. Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.
Morini M; Cangelosi D; Segalerba D; Marimpietri D; Raggi F; Castellano A; Fruci D; de Mora JF; Cañete A; Yáñez Y; Viprey V; Corrias MV; Carlini B; Pezzolo A; Schleiermacher G; Mazzocco K; Ladenstein R; Sementa AR; Conte M; Garaventa A; Burchill S; Luksch R; Bosco MC; Eva A; Varesio L
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575060
[TBL] [Abstract][Full Text] [Related]
22. Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma.
Andolfo I; Lasorsa VA; Manna F; Rosato BE; Formicola D; Iolascon A; Capasso M
J Cell Mol Med; 2020 Jun; 24(11):6459-6471. PubMed ID: 32336043
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
24. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
25. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
26. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
[TBL] [Abstract][Full Text] [Related]
27. Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma.
Barco S; Lavarello C; Cangelosi D; Morini M; Eva A; Oneto L; Uva P; Tripodi G; Garaventa A; Conte M; Petretto A; Cangemi G
Front Oncol; 2022; 12():845936. PubMed ID: 35756625
[TBL] [Abstract][Full Text] [Related]
28. Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma.
Agarwal S; Ghosh R; Chen Z; Lakoma A; Gunaratne PH; Kim ES; Shohet JM
Oncotarget; 2016 Apr; 7(17):24018-26. PubMed ID: 26993602
[TBL] [Abstract][Full Text] [Related]
29. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
30. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
31. Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children.
Zhao Q; Jin M; Zhang DW; Zhao W; Wang XS; Yue ZX; Duan C; Huang C; Ma XL
Chin Med J (Engl); 2018 May; 131(9):1075-1078. PubMed ID: 29692379
[TBL] [Abstract][Full Text] [Related]
32. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma.
Yang J; Zhou J; Li C; Wang S
PLoS One; 2021; 16(12):e0260876. PubMed ID: 34879089
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.
Morandi F; Scaruffi P; Gallo F; Stigliani S; Moretti S; Bonassi S; Gambini C; Mazzocco K; Fardin P; Haupt R; Arcamone G; ; Pistoia V; Tonini GP; Corrias MV
PLoS One; 2012; 7(1):e29922. PubMed ID: 22253825
[TBL] [Abstract][Full Text] [Related]
35. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
[TBL] [Abstract][Full Text] [Related]
36. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
[TBL] [Abstract][Full Text] [Related]
37. lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma.
Yu Y; Chen F; Yang Y; Jin Y; Shi J; Han S; Chu P; Lu J; Tai J; Wang S; Yang W; Wang H; Guo Y; Ni X
Int J Oncol; 2019 Jul; 55(1):93-102. PubMed ID: 31180520
[TBL] [Abstract][Full Text] [Related]
38. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A; Uccella S; Marchiori D; La Rosa S; Daraspe J; Balmas Bourloud K; Beck Popovic M; Eugster PJ; Grouzmann E; Abid K
Front Endocrinol (Lausanne); 2022; 13():1027856. PubMed ID: 36531507
[TBL] [Abstract][Full Text] [Related]
39. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
40. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
Sandoval JA; Turner KE; Hoelz DJ; Rescorla FJ; Hickey RJ; Malkas LH
J Surg Res; 2007 Oct; 142(2):268-74. PubMed ID: 17727886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
